# COVID-19-Related Opioid Treatment Policy Evaluation

> **NCT05028998** · — · UNKNOWN · sponsor: **Boston VA Research Institute, Inc.** · enrollment: 110 (estimated)

## Conditions studied

- Opioid-use Disorder
- Alcohol Use Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05028998
- **Lead sponsor:** Boston VA Research Institute, Inc.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-15
- **Primary completion:** 2023-07-27
- **Final completion:** 2023-08-31
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2023-08-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05028998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05028998, "COVID-19-Related Opioid Treatment Policy Evaluation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05028998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*